Characteristics of the first 615 patients enrolled in Pacific R: A study of the first real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy - Girard, N.; Fietkau, Rainer; Garassino, M.; Garrido, Pilar; Field, J. K.; Peters, S.; Smit, H. J. M.; Perol, M.; Merle, P.; Sibille, A.; Markman, B.; Bouchaab, H.; et al. (ANNALS OF ONCOLOGY, 2020)
CRIS-Team WoS Importer:2020-10-30